Home Latest Filings Latest Buys Latest Sells Institutions Derivatives Hot Buys Data Screener Email Alerts Insider Charts
RVNC - As of  05/15/24, 12:51:59 AM:   19 Insider Transactions.

Sector: Healthcare    Industry: Biotechnology
Prev Close:$13.25  Avg Vol(3m): 303,200  P/E: 0.00  EPS: -3.07

Email this page to a friend.    Insider Transactions for RVNC

Buy/Sell* Filed Date Subject Symbol Acquirer Pct Owned Details
S 2020-08-10 09:43:11.0 Revance Therapeutics RVNC GIC Private Ltd 5.21% view
S 2020-02-05 15:17:54.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 7.9% view
B 2020-01-08 15:11:05.0 Revance Therapeutics RVNC ArrowMark Colorado Holdings LLC 10.82% view
B 2019-08-12 16:09:31.0 Revance Therapeutics RVNC ArrowMark Colorado Holdings LLC 6.25% view
S 2019-02-13 14:39:32.0 Revance Therapeutics RVNC NovaQuest Pharma Opportunities Fund III 4.2% view
B 2019-02-12 10:00:55.0 Revance Therapeutics RVNC BlackRock Inc 8.7% view
S 2019-01-29 13:56:12.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 8.0% view
B 2019-01-04 09:29:11.0 Revance Therapeutics RVNC WELLINGTON MANAGEMENT GROUP LLP 10.38% view
B 2018-04-09 17:28:57.0 Revance Therapeutics RVNC ArrowMark Colorado Holdings LLC 9.84% view
S 2018-02-07 15:10:34.0 Revance Therapeutics RVNC FRANKLIN RESOURCES INC 5.9% view
S 2018-01-25 14:09:56.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 6.0% view
B 2017-02-13 10:22:13.0 Revance Therapeutics RVNC Arrowpoint Asset Management 7.1% view
S 2017-02-08 13:05:24.0 Revance Therapeutics RVNC NovaQuest Pharma Opportunities Fund III 10.9% view
B 2017-01-25 17:23:52.0 Revance Therapeutics RVNC BlackRock Inc 7.1% view
S 2016-02-12 12:44:32.0 Revance Therapeutics RVNC Essex Woodlands Health Ventures VIII 11.3% view
B 2016-02-09 12:42:31.0 Revance Therapeutics RVNC BlackRock Inc 5.6% view
B 2016-01-26 14:56:56.0 Revance Therapeutics RVNC Bank of New York Mellon Corp 10.4% view
B 2015-12-07 16:07:13.0 Revance Therapeutics RVNC JPMORGAN CHASE & CO 13.1% view
B 2015-02-13 16:29:53.0 Revance Therapeutics RVNC Visium Asset Management 11.6% view
* Institutions do not report transaction buy/sell types directly. To help members better understand the transactions, this column is filled by InsiderCow's best-effort interpretations.